{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-080719","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2024-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.448057+00:00","generated_at":"2026-05-31T03:21:22.048226+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"TherapeuticsMD sets 2024 annual meeting for Dec 5; proxy deadlines Sep 30","bullets":["2024 Annual Meeting scheduled for December 5, 2024; record date October 17, 2024.","Stockholder proposals for inclusion in proxy materials (Rule 14a-8) must be received by September 30, 2024.","Director nominations and other proposals must also be submitted by close of business September 30, 2024.","Meeting is more than 30 days after anniversary of 2023 meeting, triggering revised deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-080719","json":"https://secwatch.observer/filing/0001213900-24-080719.json","markdown":"https://secwatch.observer/filing/0001213900-24-080719.md","text":"https://secwatch.observer/filing/0001213900-24-080719.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000121390024080719/0001213900-24-080719-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000121390024080719/ea0215273-8k_therap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:21:22.048226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}